Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis

2025-10-27 — FinanzNachrichten.de

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, a clinical-stage global biopharmaceutical company, announced positive results from the Phase 2 Moon…


Which Non-League sides will take part in the Isuzu FA Trophy Second Round Proper? - The Non-League Football Paper

Which Non-League sides will take part in the Isuzu FA Trophy Second Round Proper? - The Non-League Football Paper

2025-10-27 — The Non-League Football Paper

Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been confirmed, with 40 ties s…

A Studio With a Heated Solarium on West 14th for $780,000

A Studio With a Heated Solarium on West 14th for $780,000

2025-10-27 — Curbed

A Studio With a Heated Solarium on West 14th for $780,000 For under a million dollars, various housing configurations are available, inclu…

How to Navigate Complex Injury Cases Efficiently - GigWise

How to Navigate Complex Injury Cases Efficiently - GigWise

2025-10-27 — Gigwise

Navigating Complex Injury Cases Efficiently Dealing with a serious injury case can be stressful and confusing, but there are steps to make…

Top 10 at 11: Healthcare and tech lead ASX lower as CSL and Wisetech bleed - Stockhead

Top 10 at 11: Healthcare and tech lead ASX lower as CSL and Wisetech bleed - Stockhead

2025-10-27 — Stockhead

Market Update The Australian stock market is experiencing a decline, led by heavy falls in the healthcare and tech sectors, despite seven …

Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

2025-10-27 — FinanzNachrichten.de

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of N…

VIDEO: Rolls-Royce in high speed sector methanol engine world first

VIDEO: Rolls-Royce in high speed sector methanol engine world first

2025-10-27 — Marine Log

Rolls-Royce Achieves World First with Methanol Engine Rolls-Royce Power Systems has successfully tested a high-speed marine engine powered…

Is agentic AI the beginning of the end for ERP? | Computer Weekly

Is agentic AI the beginning of the end for ERP? | Computer Weekly

2025-10-27 — Computer Weekly

Agentic AI and ERP: Evolution or Supersession? Predictions of ERP's demise have been made before, but it has always adapted and survived. …

Rates of Physician Attrition From Clinical Practice Have Risen Since 2013

Rates of Physician Attrition From Clinical Practice Have Risen Since 2013

2025-10-27 — Pulmonology Advisor

Physician Attrition from Clinical Practice on the Rise A recent study has found that the rate of physician attrition from clinical practic…

Dear ASEAN Leaders: Trumpism Is Not A Temporary Phenomenon. Here’s Why?

Dear ASEAN Leaders: Trumpism Is Not A Temporary Phenomenon. Here’s Why?

2025-10-27 — Kashmir Times

Understanding Trumpism Trumpism, represented by Donald Trump as the 45th president of the United States, is a significant movement rooted …

Here’s why Utah’s Olympic organizers are in NYC this week

Here’s why Utah’s Olympic organizers are in NYC this week

2025-10-27 — Deseret News

Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are in New York City to show support for American athletes competing …

© 2025 zofran.cfd News Aggregator
About Us · Privacy Policy · Terms of Service · DMCA Notice